We work closely with clients to reduce their intellectual property-related risks. Typically this might involve:
Insights about IP Risk Management
EPO enlarged board of appeal rules that non-reproducible commercial products are prior art when assessing novelty and inventive step. A product put on the market before the filing date of a European patent application cannot be excluded from the state of the art solely because its…
Nike settles trade mark dispute with “Shoe Surgeon” Dominic Ciambrone over his high end customised shoes. He’s apparently allowed limited customization with removal of any Nike IP. StupidDope; SGB Media; hypebeast; USPTO (Acting) Director comes up with a new way to deny Inter Partes Review…
Be proactive in managing your brands, especially when entering and operating in new markets, even if online. Be quick to identify and avoid or address potential conflicts as the expense and time needed to fix will increase over time. Some key insights from the recent…
Another Repatha instalment, this time the UPC (Unified Patents Court) in Europe issued it’s first decision on infringement of second medical use claims. Regeneron’s EP 3536712 patent (licensed to Sanofi) found valid but not infringed by Repatha under a two stage test set out by…
“‘The technology is moving so fast and we’re so small, we don’t need a patent, we just need to move fast.” Wrong. Every small tech company is going to want to deal with a larger company sooner or later. You need to be fully prepared…
Trending in intellectual property at the moment: Apple ordered to pay US $502m plus compound interest to non practicing entity Optis in FRAND patent infringement appeal to UK Court of Appeal. : Judgment; Apple World Today; Reuters; Engadget; IPWatchDog; U.S. Trade Representative Releases 2025 Special…
Something went wrong. Please refresh the page and/or try again.
